Market Tracker

04/15 6:05pm ET

Alkermes Plc (NASDAQ:ALKS)

42.83
Data as of Apr 15
 +1.54 / +3.73%
Today’s Change
24.26
Today|||52-Week Range
54.25
+5.34%
Year-to-Date

Today’s Trading

Previous close41.29
Today’s open41.42
Day’s range40.97 - 43.24
Volume2,115,999
Average volume (3 months)1,350,403
Market cap$6.2B
Dividend yield--
Data as of 3:59pm ET, 04/15/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-61.83%
Earnings growth (next 5 years)+29.43%
Revenue growth (last year)+47.59%
P/E ratio329.5
Price/Sales5.42
Price/Book6.05

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...-0.25-0.21%
SLXPSalix Pharmaceutical...+0.49+0.50%
PCYCPharmacyclics Inc+2.87+3.23%
ICPTIntercept Pharmaceut...-7.03-2.75%
Data as of 3:59pm ET, 04/15/2014

Financials

Last reporting dateFebruary 27, 2014
EPS forecast (this quarter)$0.10
Annual revenue (last year)$575.5M
Annual profit (last year)$25.0M
Net profit margin4.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane Cooke
Corporate headquarters
Dublin, Dublin

Forecasts